Cargando…

The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk

Objective. Obesity-dependent diseases cause economic burden to companies. Large-scale data for working populations are lacking. Prevalence of overweight and obesity in the Boehringer Ingelheim (BI) Employee cohort and the relationship between body mass index (BMI) and cardiometabolic risk factors an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kempf, Kerstin, Martin, Stephan, Döhring, Carmen, Dugi, Klaus, Wolfram von Wolmar, Carolin, Haastert, Burkhard, Schneider, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753749/
https://www.ncbi.nlm.nih.gov/pubmed/23997947
http://dx.doi.org/10.1155/2013/159123
_version_ 1782281881572605952
author Kempf, Kerstin
Martin, Stephan
Döhring, Carmen
Dugi, Klaus
Wolfram von Wolmar, Carolin
Haastert, Burkhard
Schneider, Michael
author_facet Kempf, Kerstin
Martin, Stephan
Döhring, Carmen
Dugi, Klaus
Wolfram von Wolmar, Carolin
Haastert, Burkhard
Schneider, Michael
author_sort Kempf, Kerstin
collection PubMed
description Objective. Obesity-dependent diseases cause economic burden to companies. Large-scale data for working populations are lacking. Prevalence of overweight and obesity in the Boehringer Ingelheim (BI) Employee cohort and the relationship between body mass index (BMI) and cardiometabolic risk factors and diseases were estimated. Design and Methods. Employees (≥38 years, employed in Ingelheim ≥2 years; n = 3151) of BI Pharma GmbH & Co. KG were invited by the medical corporate department to participate in intensive health checkups. Cross-sectional analysis of baseline data collected through 2006–2011 was performed. Results. 90% of eligible subjects participated (n = 2849). Prevalences of overweight and obesity were 40% and 18% and significantly higher in men and participants ≥50 years. Cardiometabolic risk factor levels and prevalences of cardiometabolic diseases significantly increased with BMI and were higher in overweight and obese participants. Cut-points for increased risk estimated from ROC curves were ≈25 kg/m(2) for hypertension, hypercholesterolemia, arteriosclerosis, and hypertriglyceridemia and 26.7–28.0 kg/m(2) for the metabolic syndrome, insulin resistance, hyperinsulinemia, increased intima media thickness, and type 2 diabetes. Conclusion. This is the first large-scale occupational health care cohort from a single company. Cardiometabolic risk factors and diseases accumulate with increasing BMI. Occupational weight reduction programs seem to be reasonable strategies.
format Online
Article
Text
id pubmed-3753749
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37537492013-09-01 The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk Kempf, Kerstin Martin, Stephan Döhring, Carmen Dugi, Klaus Wolfram von Wolmar, Carolin Haastert, Burkhard Schneider, Michael J Obes Research Article Objective. Obesity-dependent diseases cause economic burden to companies. Large-scale data for working populations are lacking. Prevalence of overweight and obesity in the Boehringer Ingelheim (BI) Employee cohort and the relationship between body mass index (BMI) and cardiometabolic risk factors and diseases were estimated. Design and Methods. Employees (≥38 years, employed in Ingelheim ≥2 years; n = 3151) of BI Pharma GmbH & Co. KG were invited by the medical corporate department to participate in intensive health checkups. Cross-sectional analysis of baseline data collected through 2006–2011 was performed. Results. 90% of eligible subjects participated (n = 2849). Prevalences of overweight and obesity were 40% and 18% and significantly higher in men and participants ≥50 years. Cardiometabolic risk factor levels and prevalences of cardiometabolic diseases significantly increased with BMI and were higher in overweight and obese participants. Cut-points for increased risk estimated from ROC curves were ≈25 kg/m(2) for hypertension, hypercholesterolemia, arteriosclerosis, and hypertriglyceridemia and 26.7–28.0 kg/m(2) for the metabolic syndrome, insulin resistance, hyperinsulinemia, increased intima media thickness, and type 2 diabetes. Conclusion. This is the first large-scale occupational health care cohort from a single company. Cardiometabolic risk factors and diseases accumulate with increasing BMI. Occupational weight reduction programs seem to be reasonable strategies. Hindawi Publishing Corporation 2013 2013-08-12 /pmc/articles/PMC3753749/ /pubmed/23997947 http://dx.doi.org/10.1155/2013/159123 Text en Copyright © 2013 Kerstin Kempf et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kempf, Kerstin
Martin, Stephan
Döhring, Carmen
Dugi, Klaus
Wolfram von Wolmar, Carolin
Haastert, Burkhard
Schneider, Michael
The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title_full The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title_fullStr The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title_full_unstemmed The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title_short The Epidemiological Boehringer Ingelheim Employee Study—Part I: Impact of Overweight and Obesity on Cardiometabolic Risk
title_sort epidemiological boehringer ingelheim employee study—part i: impact of overweight and obesity on cardiometabolic risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753749/
https://www.ncbi.nlm.nih.gov/pubmed/23997947
http://dx.doi.org/10.1155/2013/159123
work_keys_str_mv AT kempfkerstin theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT martinstephan theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT dohringcarmen theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT dugiklaus theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT wolframvonwolmarcarolin theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT haastertburkhard theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT schneidermichael theepidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT kempfkerstin epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT martinstephan epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT dohringcarmen epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT dugiklaus epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT wolframvonwolmarcarolin epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT haastertburkhard epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk
AT schneidermichael epidemiologicalboehringeringelheimemployeestudypartiimpactofoverweightandobesityoncardiometabolicrisk